文献速递肺结节与肺癌

身高对可切除肺癌长期生存的保护作用:肺癌悖论的新特征

Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox.
PubMed 文献 · Thorax · 2024-03-15

基于法国Epithor数据库16年间61 379例可切除非小细胞肺癌患者,分析身高与长期生存的关系。调整年龄、吸烟、FEV1、WHO PS、ASA评分、切除范围、组织学类型、分期及中心随机效应后,身高每增加10 cm与更好长期生存独立相关(校正HR 0.97,95%CI 0.95–0.99),进一步调整BMI后HR相同。按BMI分层无差异关联证据(p=0.93),除IIIB–IV期外各分期身高预后意义均保持。

要点

  • 身高是可切除肺癌长期生存的独立预后因素,每增加10 cm校正HR 0.97(95%CI 0.95–0.99)。
  • 进一步调整BMI后HR相同,按BMI分层无差异关联证据(p=0.93)。
  • 除IIIB–IV期外,各疾病分期中身高预后意义均保持。

核心结论

  • 身高是可切除肺癌长期生存的独立预后因素。

研究设计与样本

  • 提取法国胸心血管外科学会Epithor数据库中16年间所有连续可切除非小细胞肺癌患者数据。
  • 共纳入61 379例患者,身高作为连续变量并按性别特异性分位数分为四类或三类分析。
  • 采用Cox比例风险回归估计身高与生存的关联,调整年龄、吸烟量、FEV1、WHO PS、ASA评分、切除范围、组织学类型、疾病分期及中心随机效应,并进一步调整BMI。

主要发现

  • 调整其他变量后,较高身高与更好长期生存显著相关(校正HR 0.97/10 cm,95%CI 0.95–0.99)。
  • 进一步调整BMI后HR相同。
  • 按年龄、ASA分级、WHO PS和组织学类型分层,身高的预后影响进一步得到确认。
  • 按BMI分层,无差异关联证据(p=0.93)。
  • 按疾病分期分层,除IIIB–IV期外各分期身高预后意义均保持。

临床怎么用

  • 可将身高作为可切除肺癌患者长期生存评估的独立预后因素之一。
  • 身高预后意义在IIIB–IV期患者中未保持,分期评估时需注意。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Unlike most malignancies, higher body mass index (BMI) is associated with a reduced risk of lung cancer and improved prognosis after surgery. However, it remains controversial whether height, one of determinants of BMI, is associated with survival independently of BMI and other confounders. METHODS: We extracted data on all consecutive patients with resectable non-small cell lung cancer included in Epithor, the French Society of Thoracic and Cardiovascular Surgery database, over a 16-year period. Height was analysed as a continuous variable, and then categorised into four or three categories, according to sex-specific quantiles. Cox proportional hazards regression was used to estimate the association of height with survival, adjusted for age, tobacco consumption, forced expiratory volume in one second (FEV1), WHO performance status (WHO PS), American Society of Anesthesiologists (ASA) score, extent of resection, histological type, stage of disease and centre as a random effect, as well as BMI in a further analysis. RESULTS: The study included 61 379 patients. Higher height was significantly associated with better long-term survival after adjustment for other variables (adjusted HR 0.97 per 10 cm higher height, 95% CI 0.95 to 0.99); additional adjustment for BMI resulted in an identical HR. The prognostic impact of height was further confirmed by stratifying by age, ASA class, WHO PS and histological type. When stratifying by BMI class, there was no evidence of a differential association (p=0.93). When stratifying by stage of disease, the prognostic significance of height was maintained for all stages except IIIB-IV. CONCLUSIONS: Our study shows that height is an independent prognostic factor of resectable lung cancer.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Daffré E, Porcher R, Iannelli A, et al. Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox. Thorax. 2024. PMID: 38359923. doi:10.1136/thorax-2023-220443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。